TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis

Journal of the American Society of Nephrology

Volumn 24, Issue 10, 2013, Pages 1627-1642

  Kinashi, Hiroshi ^a   Ito, Yasuhiko ^a   Mizuno, Masashi ^a   Suzuki, Yasuhiro ^a   Terabayashi, Takeshi ^a   Nagura, Fumiko ^a   Hattori, Ryohei ^a   Matsukawa, Yoshihisa ^a   Mizuno, Tomohiro ^a   Noda, Yukihiro ^a   Nishimura, Hayato ^b   Nishio, Ryosuke ^c   Maruyama, Shoichi ^a   Imai, Enyu ^a   Matsuo, Seiichi ^a   Takei, Yoshifumi ^d  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

^c Department of Clinical Laboratory   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE GLUCONATE; CREATININE; LYMPHATIC ENDOTHELIAL HYALURONAN RECEPTOR 1; MESSENGER RNA; PODOPLANIN; PROTEIN INHIBITOR; RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1 RECEPTOR INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN C;

ADULT; AGED; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIALYSATE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY DYSFUNCTION; LYMPH VESSEL; LYMPHANGIOGENESIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MESOTHELIUM CELL; NONHUMAN; PERITONEAL BIOPSY; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS CATHETER; PERITONEAL FIBROSIS; PERITONEUM; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ULTRAFILTRATION FAILURE; UPREGULATION; UREMIA;

EID: 84885059078     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012030226     Document Type: Article

References (60)

1. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Pagé D; The Canada-USA (CANUSA) Peritoneal Dialysis Study Group: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 9: 1285-1292, 1998
2. Rumpsfeld M, McDonald SP, Johnson DW: Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 17: 271-278, 2006
3. Kawaguchi Y, Ishizaki T, Imada A, Oohira S, Kuriyama S, Nakamoto H, Nakamoto M, Hiramatu M, Maeda K, Ota K; Study Group for Withdrawal from PD in Japan: Searching for the reasons for drop-out from peritoneal dialysis: A nationwide survey in Japan. Perit Dial Int 23 [Suppl 2]: S175-S177, 2003
4. Mizuno M, Ito Y, Tanaka A, Suzuki Y, Hiramatsu H, Watanabe M, Tsuruta Y, Matsuoka T, Ito I, Tamai H, Kasuga H, Shimizu H, Kurata H, Inaguma D, Hiramatsu T, Horie M, Naruse T, Maruyama S, Imai E, Yuzawa Y, Matsuo S: Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan. Clin Exp Nephrol 15: 727-737, 2011
5. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG: Metaanalysis: Peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J AmSoc Nephrol 17: 2591-2598, 2006
6. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT; Peritoneal Biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13: 470-479, 2002
7. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, Krediet RT: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19: 517-525, 1999
8. Sherif AM, Nakayama M, Maruyama Y, Yoshida H, Yamamoto H, Yokoyama K, Kawakami M: Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients. Nephrol Dial Transplant 21: 1675-1681, 2006
9. Tammela T, Alitalo K: Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140: 460-476, 2010
10. Alitalo K, Tammela T, Petrova TV: Lymphangiogenesis in development and human disease. Nature 438: 946-953, 2005
11. Jones N, Iljin K, Dumont DJ, Alitalo K: Tie receptors: Newmodulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2: 257-267, 2001
12. Schoppmann SF, Birner P, Stöckl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D: Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161: 947-956, 2002
13. Kodama M, Kitadai Y, Tanaka M, Kuwai T, Tanaka S, Oue N, Yasui W, Chayama K: Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Clin Cancer Res 14: 7205-7214, 2008
14. Kitadai Y, Kodama M, Cho S, Kuroda T, Ochiumi T, Kimura S, Tanaka S, Matsumura S, Yasui W, Chayama K: Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer 115: 388-392, 2005
15. Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kimura S, Chayama K: Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 95: 32-39, 2004
16. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, Ylä-Herttuala S, Jackson DG, Alitalo K, McDonald DM: Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115: 247-257, 2005
17. Baluk P, Yao LC, Feng J, Romano T, Jung SS, Schreiter JL, Yan L, Shealy DJ, McDonald DM: TNF-a drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J Clin Invest 119: 2954-2964, 2009
18. El-Chemaly S, Malide D, Zudaire E, Ikeda Y, Weinberg BA, Pacheco-Rodriguez G, Rosas IO, Aparicio M, Ren P, MacDonald SD, Wu HP, Nathan SD, Cuttitta F, McCoy JP, Gochuico BR, Moss J: Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proc Natl Acad Sci U S A 106: 3958-3963, 2009
19. Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K: Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156: 1499-1504, 2000
20. Kerjaschki D, Huttary N, Raab I, Regele H, Bojarski-Nagy K, Bartel G, Kröber SM, Greinix H, Rosenmaier A, Karlhofer F, Wick N, Mazal PR: Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 12: 230-234, 2006
21. Kerjaschki D, Regele HM, Moosberger I, Nagy-Bojarski K, Watschinger B, Soleiman A, Birner P, Krieger S, Hovorka A, Silberhumer G, Laakkonen P, Petrova T, Langer B, Raab I: Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15: 603-612, 2004
22. Sakamoto I, Ito Y, Mizuno M, Suzuki Y, Sawai A, Tanaka A, Maruyama S, Takei Y, Yuzawa Y, Matsuo S: Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int 75: 828-838, 2009
23. Suzuki Y, Ito Y, Mizuno M, Kinashi H, Sawai A, Noda Y, Mizuno T, Shimizu H, Fujita Y, Matsui K, Maruyama S, Imai E, Matsuo S, Takei Y: Transforming growth factor-b induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction. Kidney Int 81: 865-879, 2012
24. Smit W, Schouten N, van den Berg N, Langedijk MJ, Struijk DG, Krediet RT; Netherlands Ultrafiltration Failure Study Group: Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: A cross-sectional study. Perit Dial Int 24: 562-570, 2004
25. Sampimon DE, Coester AM, Struijk DG, Krediet RT: The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis. Nephrol Dial Transplant 26: 291-298, 2011
26. Heimbürger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38: 495-506, 1990
27. Fusshöller A, zur Nieden S, Grabensee B, Plum J: Peritoneal fluid and solute transport: Influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol 13: 1055-1060, 2002
28. Krediet RT: The effective lymphatic absorption rate is an accurate and useful concept in the physiology of peritoneal dialysis. Perit Dial Int 24: 309-313, 2004
29. Flessner M: Effective lymphatic absorption rate is not a useful or accurate term to use in the physiology of peritoneal dialysis. Perit Dial Int 24: 313-316, 2004
30. Nishino T, Miyazaki M, Abe K, Furusu A, Mishima Y, Harada T, Ozono Y, Koji T, Kohno S: Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. Kidney Int 64: 887-896, 2003
31. Ro Y, Hamada C, Inaba M, Io H, Kaneko K, Tomino Y: Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats. Nephrol Dial Transplant 22: 2838-2848, 2007
32. Kushiyama T, Oda T, Yamada M, Higashi K, Yamamoto K, Oshima N, Sakurai Y, Miura S, Kumagai H: Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats. Nephrol Dial Transplant 26: 3143-3154, 2011
33. Mizutani M, Ito Y, Mizuno M, Nishimura H, Suzuki Y, Hattori R, Matsukawa Y, Imai M, Oliver N, Goldschmeding R, Aten J, Krediet RT, Yuzawa Y, Matsuo S: Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol 298: F721-F733, 2010
34. Tammela T, Saaristo A, Holopainen T, Lyytikkä J, Kotronen A, Pitkonen M, Abo-Ramadan U, Ylä-Herttuala S, Petrova TV, Alitalo K: Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med 13: 1458-1466, 2007
35. Karnezis T, Shayan R, Caesar C, Roufail S, Harris NC, Ardipradja K, Zhang YF, Williams SP, Farnsworth RH, Chai MG, Rupasinghe TW, Tull DL, Baldwin ME, Sloan EK, Fox SB, Achen MG, Stacker SA: VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 21: 181-195, 2012
36. Iwata C, Kano MR, Komuro A, Oka M, Kiyono K, Johansson E, Morishita Y, Yashiro M, Hirakawa K, Kaminishi M, Miyazono K: Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res 67: 10181-10189, 2007
37. Kim YL: Update onmechanisms of ultrafiltration failure. Perit Dial Int 29 [Suppl 2]: S123-S127, 2009
38. Parikova A, Smit W, Struijk DG, Krediet RT: Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. Kidney Int 70: 1988-1994, 2006
39. Ni J, Verbavatz JM, Rippe A, Boisdé I, Moulin P, Rippe B, Verkman AS, Devuyst O: Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int 69: 1518-1525, 2006
40. de Arteaga J, Ledesma F, Garay G, Chiurchiu C, de la Fuente J, Douthat W, Massari P, Terryn S, Devuyst O: High-dose steroid treatment increases freewater transport in peritoneal dialysis patients. NephrolDial Transplant 26: 4142-4145, 2011
41. Yang WS, Tsai TJ, Shih CL, Huang JW, Chuang HF, Chen MH, Fang CC: Intraperitoneal vascular endothelial growth factor C level is related to peritoneal dialysis ultrafiltration. Blood Purif 28: 69-74, 2009
42. Matsui K, Nagy-Bojarsky K, Laakkonen P, Krieger S, Mechtler K, Uchida S, Geleff S, Kang DH, Johnson RJ, Kerjaschki D: Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: Aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol 14: 1981-1989, 2003
43. Kerjaschki D: The crucial role of macrophages in lymphangiogenesis. J Clin Invest 115: 2316-2319, 2005
44. Kim KE, Koh YJ, Jeon BH, Jang C, Han J, Kataru RP, Schwendener RA, Kim JM, Koh GY: Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide- induced aberrant lymphangiogenesis and lymphatic function in the diaphragm. Am J Pathol 175: 1733-1745, 2009
45. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M, Van Rooijen N, Takenaka H, D'Amore PA, Stein-Streilein J, Losordo DW, Streilein JW: Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115: 2363-2372, 2005
46. Ristimäki A, Narko K, Enholm B, Joukov V, Alitalo K: Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273: 8413-8418, 1998
47. Lai KN, Lai KB, Szeto CC, Lam CW, Leung JC: Growth factors in continuous ambulatory peritoneal dialysis effluent. Their relation with peritoneal transport of small solutes. Am J Nephrol 19: 416-422, 1999
48. Zweers MM, de Waart DR, Smit W, Struijk DG, Krediet RT: Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab ClinMed 134: 124-132, 1999
49. Kang DH, Hong YS, Lim HJ, Choi JH, Han DS, Yoon KI: High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: Effect of cytokine costimulation. Perit Dial Int 19: 221-230, 1999
50. De Vriese AS, Tilton RG, Mortier S, Lameire NH: Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant 21: 2549-2555, 2006
51. Leung JC, Chan LY, Tam KY, Tang SC, Lam MF, Cheng AS, Chu KM, Lai KN: Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis. Nephrol Dial Transplant 24: 458-469, 2009
52. Abu-Hijleh MF, Habbal OA, Moqattash ST: The role of the diaphragmin lymphatic absorption from the peritoneal cavity. J Anat 186: 453-467, 1995
53. Mactier RA, Khanna R, Twardowski Z, Moore H, Nolph KD: Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis. J Clin Invest 80: 1311-1316, 1987
54. Peritoneal Dialysis Adequacy 2006 Work Group: Clinical practice guidelines for peritoneal adequacy, update 2006. Am J Kidney Dis 48 [Suppl 1]: S91-S175, 2006
55. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC: Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 35: 644-652, 2000
56. Twardowski ZJ: The fast peritoneal equilibration test. Semin Dial 3: 141-142, 1990
57. Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, Hirano H; Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal Dialysis: Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: A quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol 3: 720-728, 2008
58. Nishimura H, Ito Y, Mizuno M, Tanaka A, Morita Y, Maruyama S, Yuzawa Y, Matsuo S: Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model. Am J Physiol Renal Physiol 294: F1084-F1093, 2008
59. Grimaldi A, Moriondo A, Sciacca L, Guidali ML, Tettamanti G, Negrini D: Functional arrangement of rat diaphragmatic initial lymphatic network. AmJ Physiol Heart Circ Physiol 291: H876-H885, 2006
60. Kato H, Mizuno T, Mizuno M, Sawai A, Suzuki Y, Kinashi H, Nagura F, Maruyama S, Noda Y, Yamada K, Matsuo S, Ito Y: Atrial natriuretic peptide ameliorates peritoneal fibrosis in rat peritonitis model. Nephrol Dial Transplant 27: 526-536, 2012